48 related articles for article (PubMed ID: 29680257)
1. Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.
Banerjee R; Wang V; Huang CY; Pandita D; Leonard MK; LaRue S; Ahmadi M; Kaplan L; Ai WZ; Fakhri B; Spinner M; Seshadri MR; Pampaloni MH; Andreadis CB
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3349-3353. PubMed ID: 37300573
[TBL] [Abstract][Full Text] [Related]
2. Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).
Maier FC; Kneilling M; Reischl G; Cay F; Bukala D; Schmid A; Judenhofer MS; Röcken M; Machulla HJ; Pichler BJ
Radiat Oncol; 2011 Nov; 6():165. PubMed ID: 22118419
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Tumor Hypoxia Metrics Derived from
Scarpelli ML; Healey DR; Fuentes A; Kodibagkar VD; Quarles CC
Tomography; 2020 Dec; 6(4):379-388. PubMed ID: 33364428
[No Abstract] [Full Text] [Related]
4. Improving Tumor Hypoxia Location in
Gertsenshteyn I; Epel B; Barth E; Leoni L; Markiewicz E; Tsai HM; Fan X; Giurcanu M; Bodero D; Zamora M; Sundramoorthy S; Kim H; Freifelder R; Bhuiyan M; Kucharski A; Karczmar G; Kao CM; Halpern H; Chen CT
Radiol Imaging Cancer; 2021 Mar; 3(2):e200104. PubMed ID: 33817651
[TBL] [Abstract][Full Text] [Related]
5. Exploring Geometrical, Electronic and Spectroscopic Properties of 2-Nitroimidazole-Based Radiopharmaceuticals via Computational Chemistry Methods.
Crișan G; Stan Ș; Chiș V
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611785
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility of imaging methods used to measure hypoxia in cervical cancer.
Waller J; Onderdonk B; Flood A; Swartz H; Shah J; Shah A; Aydogan B; Halpern H; Hasan Y
Br J Radiol; 2020 Jul; 93(1111):20190640. PubMed ID: 32286849
[TBL] [Abstract][Full Text] [Related]
7. Detecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy.
Chapman DW; Jans HS; Ma I; Mercer JR; Wiebe LI; Wuest M; Moore RB
EJNMMI Res; 2014 Dec; 4(1):27. PubMed ID: 26116107
[TBL] [Abstract][Full Text] [Related]
8. Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma.
Maeng YI; Lee SJ
Yeungnam Univ J Med; 2021 Jul; 38(3):231-234. PubMed ID: 32911592
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic radiobioassays: a radiometric detection tool for understanding cellular physiology and pharmacokinetics.
Liu Z; Lan X
Lab Chip; 2019 Jul; 19(14):2315-2339. PubMed ID: 31222194
[TBL] [Abstract][Full Text] [Related]
10. Functional Imaging of Hypoxia: PET and MRI.
Perez RC; Kim D; Maxwell AWP; Camacho JC
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444446
[TBL] [Abstract][Full Text] [Related]
11. A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy.
Bouleftour W; Rowinski E; Louati S; Sotton S; Wozny AS; Moreno-Acosta P; Mery B; Rodriguez-Lafrasse C; Magne N
Med Sci Monit; 2021 Nov; 27():e934116. PubMed ID: 34728593
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET.
Huang Y; Fan J; Li Y; Fu S; Chen Y; Wu J
Front Oncol; 2021; 11():731503. PubMed ID: 34557414
[TBL] [Abstract][Full Text] [Related]
13. Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy.
Espedal H; Fonnes T; Fasmer KE; Krakstad C; Haldorsen IS
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783595
[TBL] [Abstract][Full Text] [Related]
14. Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with
Han K; Shek T; Vines D; Driscoll B; Fyles A; Jaffray D; Keller H; Metser U; Pintilie M; Xie J; Yeung I; Milosevic M
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1202-1209. PubMed ID: 29680257
[TBL] [Abstract][Full Text] [Related]
15. A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.
Servagi-Vernat S; Differding S; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1544-52. PubMed ID: 24570097
[TBL] [Abstract][Full Text] [Related]
16. Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake.
Metran-Nascente C; Yeung I; Vines DC; Metser U; Dhani NC; Green D; Milosevic M; Jaffray D; Hedley DW
J Nucl Med; 2016 Mar; 57(3):361-6. PubMed ID: 26769863
[TBL] [Abstract][Full Text] [Related]
17. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
Bollineni VR; Kerner GS; Pruim J; Steenbakkers RJ; Wiegman EM; Koole MJ; de Groot EH; Willemsen AT; Luurtsema G; Widder J; Groen HJ; Langendijk JA
J Nucl Med; 2013 Aug; 54(8):1175-80. PubMed ID: 23753185
[TBL] [Abstract][Full Text] [Related]
18. Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET: a review.
Halmos GB; Bruine de Bruin L; Langendijk JA; van der Laan BF; Pruim J; Steenbakkers RJ
Clin Nucl Med; 2014 Jan; 39(1):44-8. PubMed ID: 24152663
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia imaging agents labeled with positron emitters.
Hoigebazar L; Jeong JM
Recent Results Cancer Res; 2013; 194():285-99. PubMed ID: 22918765
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
